Ness Ziona, Israel

Maya Erlich

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Maya Erlich

Introduction

Maya Erlich, located in Ness Ziona, Israel, is an innovative inventor with a notable contribution to the field of pharmaceutical sciences. With three patents to her name, Erlich has made significant strides in the development of microencapsulated formulations.

Latest Patents

Maya Erlich's latest inventions include "Compositions comprising encapsulated tretinoin," which focuses on formulations utilizing microcapsules with a size of less than 50 μm. This innovative approach aims to enhance the delivery and effectiveness of tretinoin. Another noteworthy patent is titled "Stabilized microcapsules, method of their preparation and uses thereof." This invention involves core-shell microcapsules that include a core of benzoyl peroxide (BPO) or all trans retinoic acid (ATRA) encased in a metal-oxide shell, along with relevant pharmaceutical compositions and usage methods.

Career Highlights

Throughout her career, Maya has worked for distinguished companies, including Sol-Gel Technologies Ltd. and Mayne Pharma LLC. Her expertise in formulating microencapsulation techniques has paved the way for advancements in pharmaceutical delivery systems.

Collaborations

Maya Erlich has collaborated with notable professionals such as Ofer Toledano and Karine Neimann, contributing to various research and development projects that have furthered the scope of her inventions.

Conclusion

Maya Erlich exemplifies the spirit of innovation within the pharmaceutical sector. Through her patents and collaborative efforts, she continues to influence the industry and enhance the efficacy of therapeutic treatments. As an inventor, her contributions are invaluable to the ongoing evolution of drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…